![ALS Association Pressures FDA to Approve Amylyx Drug as Agency Cuts Phase III Trial Requirement - Xtalks ALS Association Pressures FDA to Approve Amylyx Drug as Agency Cuts Phase III Trial Requirement - Xtalks](https://i0.wp.com/xtalks.com/wp-content/uploads/2021/09/ALS-scaled.jpg?resize=1098%2C600&ssl=1)
ALS Association Pressures FDA to Approve Amylyx Drug as Agency Cuts Phase III Trial Requirement - Xtalks
![Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01548-7/MediaObjects/41591_2021_1548_Fig1_HTML.png)
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine
![Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/54203763-0b7e-411e-b9f9-921c6e15c1fd/gr1_lrg.jpg)
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases
![COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study | Scientific Reports COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-14016-0/MediaObjects/41598_2022_14016_Fig1_HTML.png)